HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Clinical trial: dextofisopam in the treatment of patients with diarrhoea-predominant or alternating irritable bowel syndrome.

AbstractBACKGROUND:
Dextofisopam modulates stimulated activity in animal models of stress, altered bowel motility, and visceral hypersensitivity.
AIM:
To evaluate the effects of dextofisopam in men and women with diarrhoea-predominant or alternating irritable bowel syndrome (IBS) (d-IBS or a-IBS).
METHODS:
In this double-blind, placebo-controlled study, patients were randomly assigned to receive dextofisopam 200 mg b.d. or placebo for 12 weeks. The prospectively defined primary endpoint was number of months of adequate overall relief of IBS symptoms. Bowel function was assessed primarily via stool frequency and consistency.
RESULTS:
Of 140 enrolled patients, 66 received dextofisopam and 74 placebo; 73% of the patients were women, and 78% had d-IBS. Dextofisopam was superior to placebo on the primary endpoint (P = 0.033). In d-IBS patients treated with dextofisopam, both men and women had improved stool consistency, but stool frequency was reduced only in women. Benefit diminished over time on the primary endpoint, but persisted on frequency and consistency. Dextofisopam and placebo had similar rates and types of adverse events, with more events of worsening abdominal pain with dextofisopam (12% vs. 4%) and more headaches with placebo (12% vs. 5%). Constipation was rare.
CONCLUSION:
Dextofisopam should be further evaluated as a new treatment for men and women with d-IBS and a-IBS.
AuthorsS M Leventer, K Raudibaugh, C L Frissora, N Kassem, J C Keogh, J Phillips, A W Mangel
JournalAlimentary pharmacology & therapeutics (Aliment Pharmacol Ther) Vol. 27 Issue 2 Pg. 197-206 (Jan 15 2008) ISSN: 1365-2036 [Electronic] England
PMID17973974 (Publication Type: Clinical Trial, Phase II, Journal Article, Multicenter Study, Randomized Controlled Trial, Research Support, Non-U.S. Gov't)
Chemical References
  • Antidiarrheals
  • Placebos
  • Benzodiazepines
  • tofisopam
Topics
  • Abdominal Pain (chemically induced)
  • Adult
  • Aged
  • Antidiarrheals (therapeutic use)
  • Benzodiazepines (therapeutic use)
  • Diarrhea (drug therapy)
  • Double-Blind Method
  • Female
  • Humans
  • Irritable Bowel Syndrome (drug therapy, physiopathology)
  • Male
  • Middle Aged
  • Patient Satisfaction
  • Placebos
  • Stereoisomerism

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: